This drug inhibits chimeric Bcr/Abl kinase, i.e. a truncated fusion protein generated by chromosomal translocation of a breakpoint cluster region (Bcr) with the Abl gene that has also been referred to as the Philadelphia chromosome in leukaemia patients. The gene discussed is BCR; the disease is leukemia.